Pharmaceutical Manufacturing of Sore Throat Lozenges

The contract entails the manufacturing of sore throat lozenges containing benzocaine and menthol, produced to match commercial product specifications. The manufacturing process must adhere strictly to FDA regulations, current Good Manufacturing Practices (cGMP), and military-specific labeling standards, ensuring product quality, safety, and compliance with defense requirements. The production is aimed at fulfilling the needs of the Department of Defense through its Medical Supply Chain Pharmaceutical FSA. This subcontract opportunity, identified by the NAICS code 325412, was posted on May 19, 2026, with a response deadline of May 26, 2026. It is focused on pharmaceutical manufacturing and is solicited by the Department of Defense, emphasizing the need for experienced contractors capable of delivering compliant pharmaceutical products to military specifications. The contract details, including solicitation number and location specifics, are accessible via the provided government procurement portal link.